Moreover, cancer treatment with recombinant human IL-6 has been found to induced anemia and hypoferremia [36], and a cancer-induced anemia mouse model has been established by inoculation with IL-6-producing human or mouse tumor cell lines [37]. This evidence concerns the gene IL6 and anemia.